XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.

[1]  Jing-yi Shi,et al.  Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis. , 2014, Gene.

[2]  Shan Li,et al.  DNA Repair Gene XRCC1 Polymorphisms, Smoking, and Bladder Cancer Risk: A Meta-Analysis , 2013, PloS one.

[3]  Wei Chen,et al.  XRCC1 Arg194Trp and Arg280His Polymorphisms Increase Bladder Cancer Risk in Asian Population: Evidence from a Meta-Analysis , 2013, PloS one.

[4]  Y. Hsueh,et al.  Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan. , 2013, Environmental research.

[5]  E. Tokar,et al.  Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype. , 2013, Chemical research in toxicology.

[6]  Arthur P. Grollman,et al.  Aristolochic acid-associated urothelial cancer in Taiwan , 2012, Proceedings of the National Academy of Sciences.

[7]  Z. Hseu,et al.  Partitioning of arsenic in soil-crop systems irrigated using groundwater: a case study of rice paddy soils in southwestern Taiwan. , 2012, Chemosphere.

[8]  A. J. Gandolfi,et al.  Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. , 2011, Toxicology and applied pharmacology.

[9]  A. Hartwig,et al.  Arsenicals affect base excision repair by several mechanisms. , 2011, Mutation research.

[10]  Shiuh-Jen Jiang,et al.  Speciation analysis of arsenic compounds in edible oil by ion chromatography-inductively coupled plasma mass spectrometry. , 2011, Journal of chromatography. A.

[11]  Y. Hsueh,et al.  Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk. , 2011, The Science of the total environment.

[12]  Shiuh-Jen Jiang,et al.  Microwave-assisted Extraction and Ion Chromatography Dynamic Reaction Cell Inductively Coupled Plasma Mass Spectrometry for the Speciation Analysis of Arsenic and Selenium in Cereals , 2011, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[13]  Kamaleshwar P Singh,et al.  Chronic exposure to arsenic causes increased cell survival, DNA damage, and increased expression of mitochondrial transcription factor A (mtTFA) in human prostate epithelial cells. , 2011, Chemical research in toxicology.

[14]  K. Chaudhuri,et al.  Arsenic-induced cell proliferation is associated with enhanced ROS generation, Erk signaling and CyclinA expression. , 2010, Toxicology letters.

[15]  C. Liao,et al.  Assessing the cancer risk associated with arsenic-contaminated seafood. , 2010, Journal of hazardous materials.

[16]  Rory Conolly,et al.  Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. , 2010, Chemical research in toxicology.

[17]  B. Diwan,et al.  Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype , 2009, Environmental health perspectives.

[18]  D. Wolf,et al.  Dimethylarsinic Acid in Drinking Water Changed the Morphology of Urinary Bladder but Not the Expression of DNA Repair Genes of Bladder Transitional Epithelium in F344 Rats , 2009, Toxicologic pathology.

[19]  Chien-Jen Chen,et al.  SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan. , 2008, Toxicology and applied pharmacology.

[20]  Karen H. Almeida,et al.  A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. , 2007, DNA repair.

[21]  Y. Hsueh,et al.  Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. , 2007, Toxicology and applied pharmacology.

[22]  P. Brennan,et al.  Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. , 2005, American journal of epidemiology.

[23]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[24]  G. Fròsina.  CommentaryDNA Base Excision Repair Defects in Human Pathologies , 2004, Free radical research.

[25]  M. Spitz,et al.  From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. , 2003, DNA repair.

[26]  D. Melton,et al.  Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer , 2003, British Journal of Cancer.

[27]  Thomas J. Smith,et al.  Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.

[28]  M. Vahter.  Mechanisms of arsenic biotransformation. , 2002, Toxicology.

[29]  Y. Hsueh,et al.  Stability of arsenic species and insoluble arsenic in human urine. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  I. Jaspers,et al.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. , 2002, Environmental health perspectives.

[31]  J. Luo,et al.  Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. , 2002, Mutation research.

[32]  Y. Hsueh,et al.  Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. , 2002, Toxicology letters.

[33]  H. Mohrenweiser,et al.  Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. , 2001, Carcinogenesis.

[34]  C I Amos,et al.  Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. , 2001, Cancer research.

[35]  Jack A. Taylor,et al.  DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  S. Z. Abdel‐Rahman,et al.  The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. , 2000, Cancer letters.

[37]  C. Wilson,et al.  Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation , 2000, Nature Cell Biology.

[38]  W. Cullen,et al.  Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells , 2000, Archives of Toxicology.

[39]  L. Thompson,et al.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. , 1999, Genes & development.

[40]  B. Pan,et al.  Solution structure of the single-strand break repair protein XRCC1 N-terminal domain , 1999, Nature Structural Biology.

[41]  W. de Laat,et al.  Molecular mechanism of nucleotide excision repair. , 1999, Genes & development.

[42]  Y. Hsueh,et al.  Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. , 1998, Journal of toxicology and environmental health. Part A.

[43]  J. Lamerdin,et al.  XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. , 1998, Molecular cell.

[44]  I. M. Jones,et al.  Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. , 1998, Cancer research.

[45]  A. Abbondandolo,et al.  Involvement of XRCC1 and DNA Ligase III Gene Products in DNA Base Excision Repair* , 1997, The Journal of Biological Chemistry.

[46]  Y. Hsueh,et al.  Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[48]  A. Smith,et al.  Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. , 1993, Environmental research.

[49]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[50]  L. Thompson,et al.  Molecular cloning and biological characterization of a human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells , 1988, Molecular and cellular biology.

[51]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[52]  S. You,et al.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. , 1986, British Journal of Cancer.

[53]  E. White,et al.  Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. , 2014, Urologic oncology.

[54]  D. Saleh,et al.  Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt. , 2014, Urologic oncology.

[55]  J. Persson,et al.  Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer. , 2014, Urologic oncology.

[56]  Y. Hsueh,et al.  Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. , 2008, Toxicology and applied pharmacology.

[57]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[58]  J. Harman.  Letter: Realistic goals for smoking and health. , 1974, Lancet.